A Study to Investigate the Effects of Impaired Hepatic Function on Velzatinib

Summary

This study evaluates the pharmacokinetics (PK), safety, and tolerability of velzatinib in participants with mild, moderate, and severe hepatic impairment (HI) and participants with normal hepatic function.

Timeline

Start

2026-11-10

Primary completion

2028-04-25

Completion

2028-04-25

Drugs

Indications